Literature DB >> 3166486

The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia.

H S Maurer1, P G Steinherz, P S Gaynon, J Z Finklestein, H N Sather, G H Reaman, W A Bleyer, G D Hammond.   

Abstract

Data were collected from 124 patients with newly diagnosed acute lymphoblastic leukemia (ALL) and WBC greater than 200,000/microL seen at institutions affiliated with the Children's Cancer Study Group (CCSG) from April 1981 to May 1983. The presenting characteristics, initial management, early complications, and outcome were reviewed. All the children received vigorous intravenous (IV) hydration, alkalinization of the urine, and allopurinol. Thirty-two patients were started on full therapy with no additional measure. One or more special measures believed to reduce the complications of leukostasis and blast cell lysis were administered to 92 patients as follows: small initial doses of prednisone, 63; emergency cranial irradiation, 26; exchange transfusion, 21; and leukopheresis, 19. The incidence of CNS hemorrhage was only 3% (4/124). Seven patients expired during induction and four failed to achieve a remission by day 28. Nineteen patients (15%) had documented bacterial or fungal sepsis. Mild to moderate electrolyte abnormalities occurred in 29 patients: three patients required renal dialysis. Pretreatment with small doses of prednisone did not decrease the incidence of electrolyte abnormalities in those patients when compared with patients who received full chemotherapy. The event-free survival (EFS) for the 106 patients treated on one of the three intensive pilot studies is 55% at 36 months. On multivariate analysis the two significant adverse prognostic factors were massive splenomegaly (P = .02) and WBC count greater than 600,000/microL (P = .05). In conclusion, in patients with hyperleukocytosis the complications of blast cell lysis and leukostasis were manageable with acceptable morbidity and minimal mortality in a group of patients treated with vigorous hydration, allopurinol, and alkalinization of the urine before beginning chemotherapy. Selected patients with severe hyperuricemia and renal dysfunction may benefit from leukopheresis. No beneficial role was demonstrated for the use of small initial doses of prednisone or emergency cranial irradiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166486     DOI: 10.1200/JCO.1988.6.9.1425

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  12 in total

Review 1.  Supportive care in patients with acute leukaemia: historical perspectives.

Authors:  Giovanna Cannas; Xavier Thomas
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

Review 2.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

3.  Complications of "very high" leukocytosis in pediatric acute leukemia patients managed without rasburicase and leukopheresis.

Authors:  Sameer Bakhshi; Rajkumar Bikramjit Singh; Khushboo Munot; Subha Pathania
Journal:  Indian J Pediatr       Date:  2014-08       Impact factor: 1.967

4.  Management of common oncologic emergencies.

Authors:  Rachna Seth; Abdus Sami Bhat
Journal:  Indian J Pediatr       Date:  2011-03-12       Impact factor: 1.967

5.  Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction.

Authors:  Daniel V Runco; Cassandra D Josephson; Sunil S Raikar; Kelly C Goldsmith; Glen Lew; Melinda Pauly; Ross M Fasano
Journal:  Transfusion       Date:  2018-02-04       Impact factor: 3.157

6.  Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications.

Authors:  Mary Kay Koenig; Clark W Sitton; Min Wang; John M Slopis
Journal:  J Child Neurol       Date:  2008-11       Impact factor: 1.987

7.  The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.

Authors:  Rosa Nguyen; Sima Jeha; Yinmei Zhou; Xueyuan Cao; Cheng Cheng; Deepa Bhojwani; Patrick Campbell; Scott C Howard; Jeffrey Rubnitz; Raul C Ribeiro; John T Sandlund; Tanja Gruber; Hiroto Inaba; Ching-Hon Pui; Monika L Metzger
Journal:  Pediatr Blood Cancer       Date:  2016-05-17       Impact factor: 3.167

8.  Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis.

Authors:  Robyn J Macfarlane; Barbara J McCully; Conrad V Fernandez
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

9.  Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation.

Authors:  Seom Gim Kong; Jung Ho Seo; So Eun Jun; Byung Ki Lee; Young Tak Lim
Journal:  Blood Res       Date:  2014-03-24

Review 10.  Management of Hyperleukocytosis.

Authors:  Antonio Ruggiero; Daniela Rizzo; Maria Amato; Riccardo Riccardi
Journal:  Curr Treat Options Oncol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.